7CAB
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
Entity
Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
1 | A, B, C | Spike glycoprotein | polymer | 1208 | 133945.5 | 3 | UniProt (P0DTC2) Pfam (PF16451) Pfam (PF09408) Pfam (PF19209) Pfam (PF01601) In PDB | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) | S glycoprotein,E2,Peplomer protein,SARS-CoV-2 Spike glycoprotein |
2 | D, E, F, G, H... | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | branched | 424.4 | 15 | In PDB GlyTouCan (G42666HT) | |||
3 | A, B, C | 2-acetamido-2-deoxy-beta-D-glucopyranose | non-polymer | 221.2 | 30 | Chemie (NAG) |
Sequence modifications
A, B, C: 1 - 1208 (UniProt: P0DTC2)
PDB | External Database | Details |
---|---|---|
Gly 682 | Arg 682 | engineered mutation |
Ser 683 | Arg 683 | engineered mutation |
Ser 685 | Arg 685 | engineered mutation |
Met 835 | Lys 835 | engineered mutation |
Met 844 | Ile 844 | engineered mutation |
Tyr 846 | Ala 846 | engineered mutation |
Ala 848 | Asp 848 | engineered mutation |
Met 849 | Leu 849 | engineered mutation |
Gln 850 | Ile 850 | engineered mutation |
Met 851 | Cys 851 | engineered mutation |
Tyr 853 | Gln 853 | engineered mutation |
Arg 854 | Lys 854 | engineered mutation |
Pro 986 | Lys 986 | engineered mutation |
Pro 987 | Val 987 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
Polymers | Number of chains | 3 |
Total formula weight | 401836.5 | |
Branched | Number of molecules | 15 |
Total formula weight | 6366.0 | |
Non-Polymers* | Number of molecules | 30 |
Total formula weight | 6636.2 | |
All* | Total formula weight | 414838.8 |